SCHEMBL3454236

SCHEMBL3454236

CCC(CO)ON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2049633 0.81
SCHEMBL2560372 0.81
SCHEMBL25379957 0.78
Hydrochloric Acid SCHEMBL4572764 0.78
SCHEMBL325804 0.75 TSHR (0.40)
SCHEMBL16944229 0.74
SCHEMBL26277652 0.74
SCHEMBL4557044 0.73
SCHEMBL518870 0.73
SCHEMBL10204097 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536717-B1 AMINOTHIAZOLONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-06-04 EP disclosed
WO-2009039442-A9 NFIA IN GLIAL FATE DETERMINATION, GLIOMA THERAPY AND ASTROCYTOMA TREATMENT CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2010-11-18 WO disclosed
WO-2009039442-A1 NFIA IN GLIAL FATE DETERMINATION, GLIOMA THERAPY AND ASTROCYTOMA TREATMENT CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2009-03-26 WO disclosed